If you are weighing up China as a place to get a diagnosis, a screening workup, or a second opinion, one practical question almost never gets answered: where can you actually request AI-assisted diagnostics, and how do you confirm the software reading your scan is a regulated medical device rather than a demo? This article is the checklist version of that answer — what to ask for when you book, which kinds of facilities already run these tools in routine workflow, and how to verify the qualification behind them.
The short version: AI-assisted cytology and imaging reads are not confined to a flagship research hospital in China. They sit inside commercial laboratory chains and in a substantial number of Grade-3A (tertiary, or 三甲) hospitals, which means an international patient can request them as part of an ordinary appointment — and should know the wording to use.
What changed: AI reads moved into routine service, not pilots
On 5 November 2026, a strategic cooperation agreement was signed between Dian Technology and Dian's laboratory operation to co-develop medical AI models and push them into clinical application. The reported focus is the iMedImage medical imaging large model and the iMedLoop imaging AI development platform, with iMedImage described as supporting more than 26 clinical specialties and over 4,000 disease diagnostic models.
Two deployment numbers from the same report matter more to a patient than model branding. Dian states it has put 158 model projects into production across 99 hospitals — 65 of them Grade-3A — and more than 400 medical institutions nationwide. And in May 2026, an "AI AutoVision" stained cell image analysis software obtained an NMPA Class II medical device registration certificate, the regulatory milestone that separates a clinically deployable product from a research tool.
The signing took place during the awards event of the 2026 Global Medical Imaging AI Recognition Competition, hosted by the National Healthcare Security Administration and the Zhejiang provincial government, as part of Zhejiang's "digital brain" push. Institutional backing of that kind tells you something useful for planning: these capabilities are being built into ordinary reporting pipelines, not kept as a showcase.
For you as a patient, the consequence is simple. AI assistance is now a line item you can ask for by name, in the same way you would ask for a contrast-enhanced study instead of a plain one.
The two channels where AI-assisted diagnostics are actually available
Beating around different hospitals randomly is the wrong approach. The realistic map has two main channels, and they suit different needs.
| Channel | What you can usually request by name | Best suited to | What to ask for at booking |
|---|---|---|---|
| Chain third-party laboratories (ICLs) | AI-assisted cervical cytology screening, AI-assisted imaging reads bundled into health checkup packages, pathology image analysis | Screening, preventive checkups, second reads on samples, fast logistics between cities | Whether an AI tool is applied to your sample, the software name, its registration number, and who signs the final report |
| Grade-3A (三甲) public hospitals | AI pre-screening of CT/X-ray in busy radiology departments, AI-assisted cytology and pathology, specialist department reads | Symptomatic workups, abnormal findings needing confirmatory tests, complex or oncology cases (cancer treatment in China) | Whether AI triage is used in that department, and the registration number of the product if they say yes |
| International or VIP medical departments of large hospitals | The same hospital capability, booked in English, with a translated report | Patients who need coordination, translation and a defined schedule rather than the fastest price | All of the above, plus formatted imaging export (DICOM) and a formal report for use at home |
A chain laboratory is often the right channel when the question is "am I healthy", and a Grade-3A hospital is the right channel when the question is "what does this abnormal result mean and what do we do next". If you are coming mainly for a checkup and want the AI component explicitly included, the Shanghai checkup guide for foreign patients covers package structure; booking through a Shanghai hospital appointment service is how most patients get the specific department rather than a general slot.
What to name on the appointment: a concrete request list
Vague requests get vague answers. Ask for these in specific terms.
- "AI-assisted liquid-based cervical cytology." Stained-cell image analysis is where Class II registration has landed, which means it is a real product category with regulatory paperwork you can ask to see. Say you want the AI-assisted screen, and ask whether a cytotechnologist and pathologist re-review the flagged slides.
- "AI-assisted reading of my imaging." For chest CT, bone and joint imaging, or abdominal studies, ask whether the department uses AI triage or CAD before the radiologist's read. This is worth asking in a hospital with very high daily volume, where pre-screening is where AI earns its place.
- "A physician-signed final report, not just a machine output." In the Chinese workflow, AI is a second reader and triage layer; the diagnostic responsibility sits with a licensed clinician. If a facility offers you an AI report with no clinician signature, decline it — it is not a medical document.
- "The software name and its registration number." This is the single most discriminating question you can ask. Ask it politely and in writing where possible, and let the answer tell you how mature the deployment is.
- "Formatted imaging export." Request DICOM files and the formal report if there is any chance you will show these to a doctor at home — this is a booking-time decision, not a post-hoc one.
If you are choosing between facilities across cities rather than only Shanghai, the hospital directory and the complete medical tourism guide are the place to start before you request anything specific.
How to verify the software is genuinely cleared
The registration number is not decoration; it is the handle on a public record. Two checkpoints, and what a good answer sounds like.
| Checkpoint | A credible answer | A warning sign |
|---|---|---|
| Device class | Names Class II or Class III and gives a registration number for the exact product reading your study | "It's our own system, not a device", or the marketing name changes between staff members |
| Human over-read | Confirms a radiologist, pathologist or cytologist reviews AI output and signs the report | Offers AI output as the report itself, or cannot say who signs |
Two honest caveats. First, class is a risk category, not a league table — a Class II certificate means regulated and cleared for clinical use, it does not rank one product above another. Second, there is no patient-facing ranking of "best" diagnostic AI in China that you can consult before you book; any article claiming one is guessing. What you can do is confirm the tool is registered and confirm a clinician over-reads it.
What AI-assisted diagnostics in China will not do for you
Professional candour matters more than sales copy here, because this is health content.
An AI flag is a reason for further evaluation, not a diagnosis. A normal AI-assisted screen does not exclude disease, and an abnormal one does not confirm it — confirmatory testing is the point of going to a hospital instead of only a screening facility. Neither does a good screening capability imply anything about treatment cost, drug access, or outcome for a specific condition. Any treatment plan requires in-person assessment by a licensed physician, and if a facility offers to skip that step, that is the disqualifying fact regardless of how advanced its software looks.
Fees are the other place where you should refuse to plan from numbers. AI-assisted items may be bundled or charged as add-ons, and pricing differs by city and facility, so treat any figure quoted elsewhere as an approximation and insist on a written, itemised quote valid for your booking date.
Do findings from China carry weight abroad?
This is where a November 2026 screening story connects to a broader change in how Chinese clinical data is viewed. In September 2026, the heads of four FDA centres — CDER, CBER, CDHR and OCE — issued a joint statement that clinical evidence standards do not change depending on whether a study was conducted inside or outside the United States, while the agency expands its inspection resources for foreign trials. China's revised Good Clinical Practice rules took effect on 1 September 2026, and foreign trials intended to support a US application face defined requirements on GCP, ethics and applicability to US populations.
Read that as context, not as a guarantee: it means the documentation pathway is becoming more legible across borders, and that proper records — physician-signed reports, original imaging, professional translation — are what make your Chinese workup usable at home. If your plan is diagnosis in China and continuation with your own physician, ask for the records package at booking, and read about trial access separately rather than assuming screening infrastructure and trial access are the same thing.
Before you book: the nine-point version
- Decide whether your question is screening or workup; that picks your channel.
- Ask for AI-assisted cytology or AI-assisted imaging read by name.
- Ask for the software name and registration number.
- Ask who signs the report, and confirm a clinician over-reads the AI output.
- Request DICOM export and a translated formal report.
- Get an itemised written quote for your dates; ignore third-party price claims.
- Choose a Grade-3A hospital if the result may require confirmatory tests the same week.
- Plan the follow-up visit before you travel, not after.
- Arrange interpreter support for the consultation, not only the reception desk.
OriEast supports international patients through the whole sequence: identifying facilities where AI-assisted cytology and imaging reads are in routine use, booking the correct department at a Grade-3A hospital or checkup centre, obtaining itemised quotes, medical translation during the consultation, and assembling a records package you can take home. Send your case details through case evaluation and we will tell you plainly whether AI-assisted diagnostics in China is the right tool for your situation — or whether you would be better served elsewhere. For scheduling, visa and coordination questions, start an inquiry or contact us directly.